Elucidating the Role of Microvascular Dysfunction in Heart Disease in Women
MVD
1 other identifier
observational
40
1 country
1
Brief Summary
The purpose of this study is to determine if women with chest pain and "clean" heart blood vessels have impaired blood flow to the heart due to problems with the small blood vessels that provide blood and oxygen to the heart. Impairment in the small blood vessels will be tested using ultrasound pictures of the heart, called myocardial contrast echocardiography. Since these small blood vessels are not seen in a coronary angiogram, which is an x-ray of the heart vessels using a dye containing iodine injected in the heart vessels, the problem may remain undiagnosed in women until the heart muscle becomes severely damaged. A second purpose is to identify if there is a common trait in the population of women with this tiny blood vessel dysfunction, which will be investigated by checking blood levels of certain chemical and hormones related to heart disease. Finally, we would like to investigate the relationship between depression and stress, and heart disease. We will do this by measuring cortisol (a hormone that serves as a measure of stress) and administering questionnaires that help to identify depression and stress.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2008
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2008
CompletedFirst Submitted
Initial submission to the registry
April 18, 2008
CompletedFirst Posted
Study publicly available on registry
April 22, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2014
CompletedApril 18, 2018
April 1, 2018
6.1 years
April 18, 2008
April 16, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Elucidating the Role of Microvascular Dysfunction in Heart Disease in Women
Data collection
2008-2014
Study Arms (2)
1
Women with chest pain and "Clean" heart vessels
2
Healthy volunteers
Eligibility Criteria
Fifty non-smoking women, between 45 and 75 years of age, with chest pain will be referred to this study by clinicians at OHSU. The control group will be fifty non-smoking women with no cardiac symptoms, matched with the study group by age and risk factors. Flyers and other advertisements may be used to recruit both the study group and the control group. Criteria for exclusion from the study are pregnancy, allergy to any component in the drugs used in the study, severe asthma, known disease of the heart vessels or heart valves, active infection, cancer, uncontrolled hypertension, kidney disease and current smoking status.
You may qualify if:
- Women 45 to 75 years of age
You may not qualify if:
- Pregnancy
- Allergy to any component of the drugs: Definity®. Dipyridamole Aminophyllin or Iodine.
- Known coronary heart disease, significant valvular disease (valvular stenosis or insufficiency greater than moderate) left ventricular systolic dysfunction, congenital heart disease or cardiac shunt, pulmonary hypertension, moderate or severe asthma.
- Inability to reach the patient by mail, fax, e-mail or phone
- Active infection
- Malignancy
- Uncontrolled hypertension
- Smoking
- Severe asthma
- Kidney disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Oregon Health and Science University
Portland, Oregon, 97239, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Diana Rinkevich, MD
Oregon Health and Science University
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Diana Rinkevich, MD
Study Record Dates
First Submitted
April 18, 2008
First Posted
April 22, 2008
Study Start
January 1, 2008
Primary Completion
February 1, 2014
Study Completion
February 1, 2014
Last Updated
April 18, 2018
Record last verified: 2018-04
Data Sharing
- IPD Sharing
- Will not share
No Plan to share data.